Publications by authors named "Rachel Ohrenschall"

Background: Long-acting injectable cabotegravir and rilpivirine have demonstrated safety, acceptability, and efficacy in adults living with HIV-1. The IMPAACT 2017 study (MOCHA study) was the first to use these injectable formulations in adolescents (aged 12-17 years) living with HIV-1. Herein, we report acceptability and tolerability outcomes in cohort 1 of the study.

View Article and Find Full Text PDF

. The World Health Organization recommends biannual deworming with single-dose albendazole for all children over 1 year in regions where soil-transmitted helminths (STH) are endemic. There are limited data from the Dominican Republic (DR) on the effectiveness of deworming programs.

View Article and Find Full Text PDF

Background: Mothers of infants with congenital heart disease are at risk for depression.

Objectives: This study explored the influence on maternal depressive symptoms of several known factors for mothers in the pediatric cardiac intensive care unit, including perceived stressors, attachment, and anxiety.

Methods: This study was a secondary analysis of 30 mothers of infants awaiting cardiac surgery.

View Article and Find Full Text PDF